Humana Treasury Stock increased by 0.7% to $14.52B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 1.1%, from $14.36B to $14.52B. Over 4 years (FY 2021 to FY 2025), Treasury Stock shows an upward trend with a 9.1% CAGR.
An increase indicates active share buybacks, which can signal management's confidence in the stock or an effort to return capital to shareholders.
Treasury stock represents the cost of shares that a company has repurchased from the open market and holds in its own tr...
Standard across all public companies; peers in the pharmaceutical sector often use buybacks to manage earnings per share.
treasury_stock| Q4 '21 | Q4 '22 | Q1 '23 | Q2 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $10.16B | $12.16B | $12.22B | $12.75B | $13.66B | $14.36B | $14.41B | $14.40B | $14.37B | $14.36B | $14.46B | $14.46B | $14.42B | $14.52B |
| QoQ Change | — | +19.6% | +0.6% | +4.3% | +7.1% | +5.1% | +0.3% | -0.0% | -0.2% | -0.0% | +0.7% | +0.0% | -0.3% | +0.7% |
| YoY Change | — | +19.6% | — | — | +12.4% | +17.5% | +12.9% | — | +5.2% | +0.0% | +0.4% | +0.4% | +0.3% | +1.1% |